Aberrant expression of long noncoding RNAs (lncRNAs) has recently been identified to be involved in various diseases including cancer, suggesting that lncRNAs may play a role in BCR-ABL-mediated CML. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.